George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBerkeley Eng Regulatory News (BKY)

Share Price Information for Berkeley Eng (BKY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.00
Bid: 18.00
Ask: 20.00
Change: 0.25 (1.33%)
Spread: 2.00 (11.111%)
Open: 18.75
High: 19.00
Low: 18.75
Prev. Close: 18.75
BKY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notification of Investment Dispute

18 Nov 2022 07:00

RNS Number : 8523G
Berkeley Energia Limited
18 November 2022
 

BERKELEY ENERGIA LIMITED

NEWS RELEASE | 18 November 2022

Berkeley submits Notification of Investment Dispute

Berkeley Energia Limited ("Berkeley" or the "Company") advises that through the Company's wholly owned subsidiaries, Berkeley Minera España, S.L.U. ("BME") and Berkeley Exploration Limited ("BEL"), it has submitted a written notification of an investment dispute to the Prime Minister of Spain and the Ministry for the Ecological Transition and the Demographic Challenge ("MITECO"). Berkeley's notification informs the Kingdom of Spain of the nature of the dispute and the Energy Charter Treaty ("ECT") breaches, and proposes to seek prompt negotiations for an amicable solution pursuant to article 26.1 of the ECT.

In November 2021, the Company received formal notification from MITECO that it had rejected the Authorisation for Construction for the uranium concentrate plant as a radioactive facility ("NSC II") at the Company's Salamanca project. This decision followed the unfavourable report for the grant of NSC II issued by the Board of the Nuclear Safety Council ("NSC") in July 2021.

Berkeley strongly refutes the NSC's assessment and, in the Company's opinion, the NSC has adopted an arbitrary decision with the technical issues used as justification to issue the unfavourable report lacking in both technical and legal support.

Berkeley submitted documentation, including an 'Improvement Report' to supplement the Company's initial NSC II application, along with the corresponding arguments that address all the issues raised by the NSC, and a request for its reassessment by the NSC, to MITECO in July 2021.

Further documentation was submitted to MITECO in August 2021, in which the Company, with strongly supported arguments, dismantled all of the technical issues used by the NSC as justification to issue the unfavourable report. The Company again restated that the project is compliant with all requirements for NSC II to be awarded and requested its NSC II Application be reassessed by the NSC.

In addition, the Company requested from MITECO access to the files associated with the Authorisation for Construction and Authorisation for Dismantling and Closure for the radioactive facilities at La Haba (Badajoz) and Saelices El Chico (Salamanca), which are owned by ENUSA Industrias Avandas S.A., in order to verify and contrast the conditions approved by the competent administrative and regulatory bodies for other similar uranium projects in Spain.

Based on a detailed comparison of the different licensing files undertaken by the Company following receipt of these files, it is clear that Berkeley, in its NSC II submission, has been required to provide information that does not correspond to: (i) the regulatory framework, (ii) the scope of the current procedural stage (i.e., at the NSC II stage), and/or (iii) the criteria applied in other licensing processes for similar radioactive facilities). Accordingly, the Company considers that the NSC has acted in a discriminatory and arbitrary manner when assessing the NSC II application for the Salamanca project.

In Berkeley's strong opinion, MITECO has rejected the Company's NSC II Application without following the legally established procedure, as the Improvement Report has not been taken into account and sent to the NSC for its assessment, as requested on multiple occasions by the Company.

In this regard, the Company believes that MITECO have infringed regulations on administrative procedures in Spain but also under protection afforded to Berkeley under the ECT, which would imply that the decision on the rejection of the Company's NSC II Application is not legal.

The Company has previously submitted an administrative appeal against MITECO's decision under Spanish law in December 2021 which has still not been resolved to date.

Whilst Berkeley's focus is on resolving the current permitting situation, and ultimately advancing the Salamanca project towards production, the Company will continue to strongly defend its position and take all necessary actions to preserve its rights.

More recently, there have also been numerous media reports stating that Spain has initiated the procedure to withdraw from the ECT.

The notification of an investment dispute submitted to the Spanish Government is necessary in order to preserve the Company's rights to initiate international arbitration should the dispute not be satisfactorily resolved. The Company, however, has informed to Spanish Government that it is prepared to collaborate and remains hopeful that the dispute can be resolved amicably through prompt negotiations.

The dispute notice is an initial step to request amicable negotiations to overturn the rejection of NSC II and does not currently comment on the size of any potential damages should the dispute not be resolved amicably. Berkeley will continue to update the market in relation to this matter as required.

 

For further information please contact:

Robert Behets Francisco Bellón

Acting Managing Director Executive Director

+61 8 9322 6322 +34 923 193 903

info@berkeleyenergia.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBPBJTMTIBMPT
Date   Source Headline
26th Apr 20247:00 amRNSBoard Changes
26th Apr 20247:00 amRNSQuarterly Report March 2024
10th Apr 20247:32 amRNSCommencement of Arbitration against Spain
13th Mar 20247:05 amRNSHalf-Year Accounts
30th Jan 20247:00 amRNSQuarterly Report December 2023
2nd Jan 20247:00 amRNSExpiry of Unlisted Options
27th Dec 20237:00 amRNSPermitting update
21st Dec 20237:00 amRNSReport on Payments to Govts
21st Nov 20237:00 amRNSResult of AGM
30th Oct 20237:00 amRNSSeptember 2023 Quarterly
11th Oct 20237:00 amRNSNotice of AGM
22nd Sep 20237:00 amRNSDate of Annual General Meeting
30th Aug 20237:00 amRNS2023 Annual Report
26th Jul 20237:57 amRNSIssue of Unlisted Options
24th Jul 20237:00 amRNSQuarterly Report June 2023
19th Jul 20237:00 amRNSResults of Meeting
19th Jun 20237:00 amRNSNotice of General Meeting
31st May 20237:00 amRNSExpiry of Unlisted Options
28th Apr 20237:00 amRNSQuarterly Report March 2023
3rd Apr 202312:12 pmRNSPermitting Update
14th Mar 20237:00 amRNSHalf-year Report
7th Feb 20234:40 pmRNSSecond Price Monitoring Extn
7th Feb 20234:35 pmRNSPrice Monitoring Extension
7th Feb 20231:12 pmRNSPermitting Update
31st Jan 20237:00 amRNSQuarterly Report December 2022
26th Jan 20234:40 pmRNSSecond Price Monitoring Extn
26th Jan 20234:35 pmRNSPrice Monitoring Extension
3rd Jan 20237:00 amRNSExpiry of Unlisted Options
22nd Dec 20227:00 amRNSReport on Payments to Governments
1st Dec 20227:00 amRNSUnlisted Options
18th Nov 20227:00 amRNSNotification of Investment Dispute
15th Nov 20227:00 amRNSResult of AGM
9th Nov 20227:00 amRNSBerkeley establishes Spanish Advisory Committee
27th Oct 20227:00 amRNSQuarterly Report September 2022
20th Oct 20222:13 pmRNSPublication of a Prospectus
4th Oct 20227:00 amRNSNotice of AGM
23rd Sep 20224:35 pmRNSPrice Monitoring Extension
19th Sep 20227:45 amRNSDate of AGM
31st Aug 202210:00 amRNS2022 Annual Report
29th Jul 20227:00 amRNSQuarterly Report June 2022
5th Jul 20227:00 amRNSChange of Director’s Interest Notice
28th Jun 20227:00 amRNSStrengthening of Board with Spanish Based Director
29th Apr 20227:00 amRNSQuarterly Report March 2022
29th Apr 20227:00 amRNSQuarterly Report March 2022
5th Apr 20228:46 amRNSNotice of Initial Substantial Holder
5th Apr 20227:00 amRNSNotice of Initial Substantial Holder
1st Apr 20227:00 amRNSSettlement of OIA Claim
24th Mar 20224:36 pmRNSPrice Monitoring Extension
24th Mar 20222:00 pmRNSPrice Monitoring Extension
24th Mar 202211:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.